Document is current
Any future updates will be listed below
-
Authors
Yanik, Sean
Venkatesh, Varsha
Gordy, James T.
Alameh, Mohamad-Gabriel https://orcid.org/0000-0002-5672-6930
Meza, Jacob
Li, Yangchen
Glass, Elizabeth
Flores-Garcia, Yevel
Tam, Ying https://orcid.org/0000-0002-4083-5251
Chaiyawong, Nattawat
Sarkar, Deepti
Weissman, Drew
Markham, Richard https://orcid.org/0000-0003-3527-9147
Srinivasan, Prakash https://orcid.org/0009-0007-8370-0553
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (R01AI155598)
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 7 February 2025
First Online: 19 February 2025
Competing interests
: D.W. is named on patents describing the use of nucleoside-modified mRNA - lipid nanoparticle vaccines. Y.T. is an employee of Acuitas Therapeutics that is involved in the development of mRNA-LNP therapeutics. D.W. and M.-G.A. are listed as inventors on patents covering LNP for nucleic acid therapeutic delivery for vaccines. Y.S., V.V., J.T.G., J.M., Y.L., E.G., Y. F-G., N.C., D.S., R.M, and P.S. have no competing interests.
